MENB VACCINE
Drug
SANOFI PASTEUR INC.
Total Payments
$1.8M
Transactions
34
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $1.8M | 34 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.8M | 34 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| VAN00001 Safety and Immunogenicity of an Investigational Meningococcal Group B Vaccine in Healthy Adults | SANOFI PASTEUR INC. | $1.8M | 0 |
Top Doctors Receiving Payments for MENB VACCINE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Knoxville, TN | $1.8M | 34 |
Ad
Manufacturing Companies
- SANOFI PASTEUR INC. $1.8M
Product Information
- Type Drug
- Total Payments $1.8M
- Total Doctors 0
- Transactions 34
About MENB VACCINE
MENB VACCINE is a drug associated with $1.8M in payments to 0 healthcare providers, recorded across 34 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI PASTEUR INC..
Payment data is available from 2019 to 2019. In 2019, $1.8M was paid across 34 transactions to 0 doctors.
The most common payment nature for MENB VACCINE is "Unspecified" ($1.8M, 100.0% of total).
MENB VACCINE is associated with 1 research study, including "VAN00001 Safety and Immunogenicity of an Investigational Meningococcal Group B Vaccine in Healthy Adults" ($1.8M).